197 related articles for article (PubMed ID: 6685702)
41. [Leprosy in Brazil].
Araújo MG
Rev Soc Bras Med Trop; 2003; 36(3):373-82. PubMed ID: 12908039
[TBL] [Abstract][Full Text] [Related]
42. Trials of daily, long-term minocycline and rifampin or clarithromycin and rifampin in the treatment of borderline lepromatous and lepromatous leprosy.
Rea TH
Int J Lepr Other Mycobact Dis; 2000 Jun; 68(2):129-35. PubMed ID: 11036492
[TBL] [Abstract][Full Text] [Related]
43. Dapsone compliance in an urban field project.
Revankar CR; Naik SS; Ganapati R
Lepr India; 1983 Jan; 55(1):117-21. PubMed ID: 6876753
[TBL] [Abstract][Full Text] [Related]
44. Comparative evaluation of immunotherapeutic efficacy of BCG and mw vaccines in patients of borderline lepromatous and lepromatous leprosy.
Narang T; Kaur I; Kumar B; Radotra BD; Dogra S
Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):105-14. PubMed ID: 16830653
[TBL] [Abstract][Full Text] [Related]
45. Effect of dapsone on blood lactic and pyruvic acids in leprosy.
Sinha SN; Gupta SC; Bajaj AK; Srivastava NP; Mehrotra TN
Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):468-70. PubMed ID: 6892022
[TBL] [Abstract][Full Text] [Related]
46. Acid fast bacilli in lymph node aspirate and smears from ear lobules and fingers in long treated patients.
Kumar B; Kaur S; Gupta SK; Rajwanshi A; Darshan H
Indian J Lepr; 1984; 56(1):71-7. PubMed ID: 6384382
[TBL] [Abstract][Full Text] [Related]
47. Incidence of "chance" smear positivity among MB leprosy patients after MDT.
Vijayakumaran P; Manimozhi N; Jesudasan K
Indian J Lepr; 1995; 67(3):249-58. PubMed ID: 8576604
[TBL] [Abstract][Full Text] [Related]
48. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
Jing Z; Zhang R; Zhou D; Chen J
Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
[TBL] [Abstract][Full Text] [Related]
49. Effect of levamisole on bacterial index in BL and LL leprosy.
Bera DK; Sen PC
Int J Lepr Other Mycobact Dis; 1985 Jun; 53(2):198-200. PubMed ID: 4020207
[TBL] [Abstract][Full Text] [Related]
50. Prevalence survey of secondary dapsone resistance in leprosy in Kancheepuram and Tiruvannamalai control units of Tamil Nadu.
Neelan PN; Noordeen SK; Balakrishnan S; Pandian PR
Lepr India; 1983 Apr; 55(2):222-30. PubMed ID: 6355650
[TBL] [Abstract][Full Text] [Related]
51. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
52. Short course treatment of paucibacillary (TT/BT) leprosy cases.
Girdhar BK; Girdhar A; Ramu G; Desikan KV
Indian J Lepr; 1985; 57(3):491-8. PubMed ID: 3831086
[TBL] [Abstract][Full Text] [Related]
53. [Late-occurring cutaneous vasculitis after successful treatment of diffuse lepromatous leprosy: Lucio's phenomenon].
Fenniche S; Benmously R; Sfia M; Daoud L; Debbiche A; Ben Ayed M; Mokhtar I
Med Trop (Mars); 2007 Feb; 67(1):65-8. PubMed ID: 17506277
[TBL] [Abstract][Full Text] [Related]
54. Inactivation and relapse in bacterio-negative cases of leprosy under sulphone therapy: a 4 1/2 years follow-up.
Neelan PN
Lepr India; 1976 Oct; 48(4 Suppl):661-7. PubMed ID: 1026801
[TBL] [Abstract][Full Text] [Related]
55. A comparison of low and conventional dosages of dapsone in the treatment of lepromatous leprosy.
Iyer CG; Balakrishnan S; Ramu G
Lepr India; 1977 Jul; 49(3):372-86. PubMed ID: 592740
[TBL] [Abstract][Full Text] [Related]
56. Multidrug therapy in leprosy can prevent relapse--a retrospective study.
Biswas S; Mondal KK
Indian J Lepr; 2002; 74(4):313-8. PubMed ID: 12624979
[TBL] [Abstract][Full Text] [Related]
57. Relapse as histoid leprosy after receiving multidrug therapy (MDT); a report of three cases.
Shaw IN; Ebenezer G; Rao GS; Natrajan MM; Balasundaram B
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):272-6. PubMed ID: 11221089
[TBL] [Abstract][Full Text] [Related]
58. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
Pettit JH; Rees RJ
Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
[No Abstract] [Full Text] [Related]
59. Long-term follow up of multibacillary leprosy patients with high BI treated with WHO/MDT regimen for a fixed duration of two years.
Shaw IN; Natrajan MM; Rao GS; Jesudasan K; Christian M; Kavitha M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):405-9. PubMed ID: 11332283
[TBL] [Abstract][Full Text] [Related]
60. The relapse rate in MB leprosy patients treated with 2-years of WHO-MDT is not low.
Gelber RH; Balagon VF; Cellona RV
Int J Lepr Other Mycobact Dis; 2004 Dec; 72(4):493-500. PubMed ID: 15755209
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
